Cargando…

Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies?

Detalles Bibliográficos
Autor principal: De Angelis, Carlo
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528304/
https://www.ncbi.nlm.nih.gov/pubmed/18769606
_version_ 1782158877101391872
author De Angelis, Carlo
author_facet De Angelis, Carlo
author_sort De Angelis, Carlo
collection PubMed
description
format Text
id pubmed-2528304
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Multimed Inc.
record_format MEDLINE/PubMed
spelling pubmed-25283042008-09-03 Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies? De Angelis, Carlo Curr Oncol Invited Editorial Multimed Inc. 2008-08 /pmc/articles/PMC2528304/ /pubmed/18769606 Text en 2008 Multimed Inc.
spellingShingle Invited Editorial
De Angelis, Carlo
Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies?
title Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies?
title_full Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies?
title_fullStr Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies?
title_full_unstemmed Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies?
title_short Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies?
title_sort side effects related to systemic cancer treatment: are we changing the promethean experience with molecularly targeted therapies?
topic Invited Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528304/
https://www.ncbi.nlm.nih.gov/pubmed/18769606
work_keys_str_mv AT deangeliscarlo sideeffectsrelatedtosystemiccancertreatmentarewechangingtheprometheanexperiencewithmolecularlytargetedtherapies